HIV/Gene Therapy

Study of HIV and Twins Approved by Panel

Published in Gene Therapy Weekly, March 20th, 1995

Federal scientists plan to inject genetically altered blood cells from healthy identical twins into siblings infected with HIV to determine if the disease can be slowed.

The study involves inserting a gene that blocks HIV into the donated blood cells in hopes that the genetically engineered cells will boost the immune systems of the infected twins, said Richard Morgan, a researcher at the National Center for Human Genome Research.

An advisory committee of the U.S. National Institutes of Health (NIH) approved the experiment procedure, but it still must be approved by the U.S. Food and Drug Administration (FDA).

Morgan said that the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-03-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry